Thymoma-associated Multiorgan Autoimmunity Presenting as Severe Psoriasiform Keratotic Erythroderma 35 Years after Thymoma Diagnosis
DOI:
https://doi.org/10.2340/actadv.v106.adv-2026-0814Keywords:
Thymoma-associated multiorgan autoimmunity, Long latency, Psoriasiform erythrodermaDownloads
References
Wadhera A, Maverakis E, Mitsiades N, Lara PN, Fung MA, Lynch PJ. Thymoma-associated multiorgan autoimmunity: a graft-versus-host-like disease. J Am Acad Dermatol 2007; 57: 683–689. DOI: https://doi.org/10.1016/j.jaad.2007.02.027
Shiba K, Fujita Y, Miyazawa H, Muramatsu K, Watanabe M, Nishimura M, et al. Thymoma-associated multi-organ autoimmunity: two cases and a review of the literature. J Eur Acad Dermatol Venereol 2017; 31: e324–e326. DOI: https://doi.org/10.1111/jdv.14108
Hyobu R, Mori M, Maeda T, Fujimori K, Shimai Y, Naito M, et al. First reported case of thymoma-associated multiorgan autoimmunity induced by COVID-19. J Dermatol 2024; 51: 1674–1678. DOI: https://doi.org/10.1111/1346-8138.17519
Muramatsu K, Fujita Y, Inokuma D, Tsukinaga I, Ito K, Nishiura Y, et al. Cutaneous Manifestations of Thymoma-associated Multi-organ Autoimmunity: A Fatal Sign. Acta Derm Venereol 2016; 96: 818–819.
Carola G, Amoroso V, Cosentini D, Consoli F, Battocchio S, Di Mauro P, et al. Clinical presentation, prognosis, and treatment strategies for thymoma-associated multiorgan autoimmunity: A pooled analysis. Crit Rev Oncol Hematol 2026; 218: 105052. DOI: https://doi.org/10.1016/j.critrevonc.2025.105052
Additional Files
Published
How to Cite
License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.